

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-mediated cell contraction (GO:0070252) | 4.73064841 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.34322724 |
| 3 | response to muscle activity (GO:0014850) | 3.96545068 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 3.95611399 |
| 5 | myofibril assembly (GO:0030239) | 3.93146467 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.76747662 |
| 7 | cardiac myofibril assembly (GO:0055003) | 3.75958825 |
| 8 | actin filament-based movement (GO:0030048) | 3.73092787 |
| 9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.71320246 |
| 10 | cell adhesion mediated by integrin (GO:0033627) | 3.61977643 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.59221689 |
| 12 | sarcomere organization (GO:0045214) | 3.53789027 |
| 13 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.53325026 |
| 14 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.49977937 |
| 15 | metanephric mesenchyme development (GO:0072075) | 3.45763275 |
| 16 | tooth mineralization (GO:0034505) | 3.39448190 |
| 17 | chondrocyte proliferation (GO:0035988) | 3.29213959 |
| 18 | cell proliferation involved in metanephros development (GO:0072203) | 3.25809186 |
| 19 | skeletal muscle contraction (GO:0003009) | 3.24646162 |
| 20 | kidney mesenchyme development (GO:0072074) | 3.23187139 |
| 21 | wound healing, spreading of epidermal cells (GO:0035313) | 3.20556829 |
| 22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18667649 |
| 23 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.17049396 |
| 24 | actomyosin structure organization (GO:0031032) | 3.15000712 |
| 25 | regulation of relaxation of muscle (GO:1901077) | 3.12101008 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.11089813 |
| 27 | cellular response to zinc ion (GO:0071294) | 3.08182476 |
| 28 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.06142747 |
| 29 | endocardial cushion development (GO:0003197) | 3.05830866 |
| 30 | endodermal cell differentiation (GO:0035987) | 3.05283096 |
| 31 | collagen fibril organization (GO:0030199) | 3.04363226 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.03183372 |
| 33 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.02999659 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00964979 |
| 35 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.98153358 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 2.94649109 |
| 37 | muscle contraction (GO:0006936) | 2.91429141 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.90526720 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.90526720 |
| 40 | substrate-dependent cell migration (GO:0006929) | 2.90470704 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 2.88871495 |
| 42 | cellular response to interferon-alpha (GO:0035457) | 2.86605754 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 2.86471931 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 2.86471931 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.86471931 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.86471931 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.86471931 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 2.86471931 |
| 49 | glomerular basement membrane development (GO:0032836) | 2.85998613 |
| 50 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.85566672 |
| 51 | smooth muscle tissue development (GO:0048745) | 2.83722516 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 2.83586425 |
| 53 | B cell receptor signaling pathway (GO:0050853) | 2.82280001 |
| 54 | cell proliferation involved in kidney development (GO:0072111) | 2.79595408 |
| 55 | regulation of apoptotic cell clearance (GO:2000425) | 2.78007915 |
| 56 | negative regulation of protein localization to cell surface (GO:2000009) | 2.76553071 |
| 57 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.76362828 |
| 58 | plasma membrane repair (GO:0001778) | 2.75118690 |
| 59 | regulation of macrophage cytokine production (GO:0010935) | 2.74713055 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 2.74247576 |
| 61 | basement membrane organization (GO:0071711) | 2.73058194 |
| 62 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.72006302 |
| 63 | neutrophil activation involved in immune response (GO:0002283) | 2.69512901 |
| 64 | myoblast fusion (GO:0007520) | 2.65964802 |
| 65 | hemidesmosome assembly (GO:0031581) | 2.64745585 |
| 66 | negative regulation of protein activation cascade (GO:2000258) | 2.64546216 |
| 67 | membrane raft organization (GO:0031579) | 2.63999301 |
| 68 | striated muscle contraction (GO:0006941) | 2.63455343 |
| 69 | growth hormone receptor signaling pathway (GO:0060396) | 2.62604031 |
| 70 | cell migration involved in heart development (GO:0060973) | 2.62059012 |
| 71 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.59405447 |
| 72 | muscle system process (GO:0003012) | 2.59084063 |
| 73 | wound healing, spreading of cells (GO:0044319) | 2.57422748 |
| 74 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.56980226 |
| 75 | response to muramyl dipeptide (GO:0032495) | 2.56919179 |
| 76 | skin morphogenesis (GO:0043589) | 2.56150988 |
| 77 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.55830373 |
| 78 | negative regulation of B cell proliferation (GO:0030889) | 2.55458904 |
| 79 | regulation of complement activation (GO:0030449) | 2.55118004 |
| 80 | I-kappaB phosphorylation (GO:0007252) | 2.55043930 |
| 81 | lymph vessel development (GO:0001945) | 2.54811729 |
| 82 | negative regulation of complement activation (GO:0045916) | 2.54393977 |
| 83 | apoptotic cell clearance (GO:0043277) | 2.54391111 |
| 84 | skeletal muscle tissue development (GO:0007519) | 2.53237327 |
| 85 | positive thymic T cell selection (GO:0045059) | 2.53130064 |
| 86 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.52955575 |
| 87 | regulation of plasminogen activation (GO:0010755) | 2.52528486 |
| 88 | extracellular matrix assembly (GO:0085029) | 2.50417323 |
| 89 | response to inactivity (GO:0014854) | 2.50056348 |
| 90 | regulation of protein activation cascade (GO:2000257) | 2.49304248 |
| 91 | positive regulation of osteoblast proliferation (GO:0033690) | 2.48627195 |
| 92 | positive regulation of macrophage cytokine production (GO:0060907) | 2.48372776 |
| 93 | positive regulation of extracellular matrix organization (GO:1903055) | 2.47220929 |
| 94 | protein heterotrimerization (GO:0070208) | 2.47008595 |
| 95 | hypotonic response (GO:0006971) | 2.46450248 |
| 96 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.46098745 |
| 97 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.45396527 |
| 98 | extracellular fibril organization (GO:0043206) | 2.44141464 |
| 99 | negative regulation of fatty acid transport (GO:2000192) | 2.43929912 |
| 100 | neutrophil activation (GO:0042119) | 2.43542006 |
| 101 | collagen metabolic process (GO:0032963) | 2.43339717 |
| 102 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.43028873 |
| 103 | protein carboxylation (GO:0018214) | 2.43028873 |
| 104 | macrophage activation involved in immune response (GO:0002281) | 2.42707328 |
| 105 | skeletal muscle adaptation (GO:0043501) | 2.41820341 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.41296823 |
| 107 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.39463500 |
| 108 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.39297204 |
| 109 | actin filament depolymerization (GO:0030042) | 2.39169911 |
| 110 | renal tubule morphogenesis (GO:0061333) | 2.38933223 |
| 111 | myotube cell development (GO:0014904) | 2.38355193 |
| 112 | cell-substrate junction assembly (GO:0007044) | 2.38048760 |
| 113 | lymphangiogenesis (GO:0001946) | 2.37232077 |
| 114 | skeletal muscle fiber development (GO:0048741) | 2.37118208 |
| 115 | response to laminar fluid shear stress (GO:0034616) | 2.36862422 |
| 116 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.35400399 |
| 117 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.35324026 |
| 118 | regulation of B cell differentiation (GO:0045577) | 2.34652513 |
| 119 | response to fluid shear stress (GO:0034405) | 2.33159537 |
| 120 | collagen catabolic process (GO:0030574) | 2.32680501 |
| 121 | regulation of necroptotic process (GO:0060544) | 2.32107830 |
| 122 | muscle tissue morphogenesis (GO:0060415) | 2.32097737 |
| 123 | nephron tubule morphogenesis (GO:0072078) | 2.31765057 |
| 124 | nephron epithelium morphogenesis (GO:0072088) | 2.31765057 |
| 125 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.31727960 |
| 126 | tonic smooth muscle contraction (GO:0014820) | 2.31646055 |
| 127 | granulocyte activation (GO:0036230) | 2.31378575 |
| 128 | extracellular matrix disassembly (GO:0022617) | 2.31044851 |
| 129 | keratan sulfate catabolic process (GO:0042340) | 2.30697030 |
| 130 | germinal center formation (GO:0002467) | 2.30514558 |
| 131 | immunoglobulin mediated immune response (GO:0016064) | 2.28344711 |
| 132 | regulation of fibrinolysis (GO:0051917) | 2.28309354 |
| 133 | regulation of B cell proliferation (GO:0030888) | 2.28102945 |
| 134 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.27962216 |
| 135 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.26763093 |
| 136 | establishment of endothelial barrier (GO:0061028) | 2.26549352 |
| 137 | multicellular organismal metabolic process (GO:0044236) | 2.26251842 |
| 138 | cellular response to growth hormone stimulus (GO:0071378) | 2.24428182 |
| 139 | lung vasculature development (GO:0060426) | 2.23819885 |
| 140 | cardiac muscle hypertrophy (GO:0003300) | 2.23021178 |
| 141 | positive regulation of interleukin-12 production (GO:0032735) | 2.22996845 |
| 142 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.22691251 |
| 143 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.22643579 |
| 144 | B cell proliferation (GO:0042100) | 2.22400119 |
| 145 | multicellular organismal catabolic process (GO:0044243) | 2.22286257 |
| 146 | venous blood vessel morphogenesis (GO:0048845) | 2.22276131 |
| 147 | desmosome organization (GO:0002934) | 2.22096754 |
| 148 | actin-myosin filament sliding (GO:0033275) | 2.21964282 |
| 149 | muscle filament sliding (GO:0030049) | 2.21964282 |
| 150 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.21394880 |
| 151 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.20630112 |
| 152 | regulation of muscle hypertrophy (GO:0014743) | 2.20439511 |
| 153 | heterotypic cell-cell adhesion (GO:0034113) | 2.20095795 |
| 154 | regulation of interleukin-12 production (GO:0032655) | 2.19342074 |
| 155 | glomerular filtration (GO:0003094) | 2.18909104 |
| 156 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.18906040 |
| 157 | myeloid dendritic cell differentiation (GO:0043011) | 2.18787032 |
| 158 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.18716164 |
| 159 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.18439560 |
| 160 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.17893703 |
| 161 | axon extension involved in axon guidance (GO:0048846) | 2.17893703 |
| 162 | positive regulation of muscle hypertrophy (GO:0014742) | 2.17870764 |
| 163 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.17870764 |
| 164 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.17615468 |
| 165 | mesodermal cell differentiation (GO:0048333) | 2.16513761 |
| 166 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.16345237 |
| 167 | muscle structure development (GO:0061061) | 2.16142939 |
| 168 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.16142073 |
| 169 | regulation of gamma-delta T cell activation (GO:0046643) | 2.15700155 |
| 170 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.15355513 |
| 171 | positive regulation of macrophage differentiation (GO:0045651) | 2.14901434 |
| 172 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.14178751 |
| 173 | renal filtration (GO:0097205) | 2.14170288 |
| 174 | integrin-mediated signaling pathway (GO:0007229) | 2.13914026 |
| 175 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.12416053 |
| 176 | cellular response to vitamin D (GO:0071305) | 2.12286160 |
| 177 | negative regulation of interleukin-12 production (GO:0032695) | 2.12078249 |
| 178 | regulation of integrin activation (GO:0033623) | 2.12024705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.27401804 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.98741619 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.49377275 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.68752704 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.66419525 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.41888918 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.31673198 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.15430032 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.84014487 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.75338574 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.64220831 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.63273335 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.59341874 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53758703 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42851324 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34028867 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31196418 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.30222827 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23943732 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.11741541 |
| 21 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.97182896 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.96522791 |
| 23 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93482882 |
| 24 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.92655374 |
| 25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.90983796 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90406949 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89330146 |
| 28 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.89155495 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87900833 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.87078483 |
| 31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.86847098 |
| 32 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.85646620 |
| 33 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.83610119 |
| 34 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.83610119 |
| 35 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.80181177 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73024644 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70591164 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67649251 |
| 39 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.67544602 |
| 40 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63559757 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60411887 |
| 42 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.59334385 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.59116474 |
| 44 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58277068 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57507247 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55169722 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.54290127 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.54031077 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.52039706 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49582908 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48615717 |
| 52 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45931391 |
| 53 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45397538 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43632362 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43523439 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42509833 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.41126143 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40764987 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.40732662 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39733450 |
| 61 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.39116342 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38352431 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37495770 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.36262155 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36130090 |
| 66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34157600 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33657289 |
| 68 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.33082916 |
| 69 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31941175 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31611702 |
| 71 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31276880 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.30873445 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30770104 |
| 74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28582582 |
| 75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28582582 |
| 76 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.28196263 |
| 77 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.28196263 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27715352 |
| 79 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.27467010 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27284842 |
| 81 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.26282721 |
| 82 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26270438 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26012702 |
| 84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.24704976 |
| 85 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23606308 |
| 86 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23314208 |
| 87 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22584069 |
| 88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22547667 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22139392 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22138849 |
| 91 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21797243 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21452150 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21156600 |
| 94 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20101065 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20018265 |
| 96 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.19666768 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19183097 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19086104 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19057220 |
| 100 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.18638125 |
| 101 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.18638125 |
| 102 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18354618 |
| 103 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14610934 |
| 104 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.14604365 |
| 105 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13229237 |
| 106 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11856036 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11685815 |
| 108 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.11668386 |
| 109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10577174 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10065938 |
| 111 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08941461 |
| 112 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08307154 |
| 113 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.05975167 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05708829 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05273144 |
| 116 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04895524 |
| 117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04726037 |
| 118 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04183141 |
| 119 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04069826 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03725138 |
| 121 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03520699 |
| 122 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03507837 |
| 123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02965688 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02865256 |
| 125 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02364826 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01788179 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01594757 |
| 128 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01575149 |
| 129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01418065 |
| 130 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01217202 |
| 131 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01150856 |
| 132 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00906676 |
| 133 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00898751 |
| 134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00440699 |
| 135 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99500052 |
| 136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98512439 |
| 137 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97801357 |
| 138 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97783099 |
| 139 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97278728 |
| 140 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95724815 |
| 141 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94101604 |
| 142 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.93990013 |
| 143 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93899603 |
| 144 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93836223 |
| 145 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92942831 |
| 146 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92848192 |
| 147 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92630252 |
| 148 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92220458 |
| 149 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91458464 |
| 150 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91200306 |
| 151 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.89171636 |
| 152 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.88809489 |
| 153 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88204794 |
| 154 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.88097703 |
| 155 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87479753 |
| 156 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85933791 |
| 157 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.85782607 |
| 158 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84959573 |
| 159 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84533367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.31669201 |
| 2 | MP0005275_abnormal_skin_tensile | 3.05540513 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 3.00026857 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.88133965 |
| 5 | MP0003646_muscle_fatigue | 2.77566519 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.67197350 |
| 7 | MP0004036_abnormal_muscle_relaxation | 2.62554615 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.62274545 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.62228996 |
| 10 | MP0003566_abnormal_cell_adhesion | 2.42775696 |
| 11 | MP0003279_aneurysm | 2.34596477 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.29333270 |
| 13 | MP0005387_immune_system_phenotype | 2.10287045 |
| 14 | MP0001790_abnormal_immune_system | 2.10287045 |
| 15 | MP0003303_peritoneal_inflammation | 2.09036323 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.08514796 |
| 17 | MP0004510_myositis | 2.02932940 |
| 18 | MP0000013_abnormal_adipose_tissue | 2.01236190 |
| 19 | MP0002106_abnormal_muscle_physiology | 1.97709756 |
| 20 | MP0005369_muscle_phenotype | 1.92033779 |
| 21 | MP0005620_abnormal_muscle_contractility | 1.91178441 |
| 22 | MP0000685_abnormal_immune_system | 1.87903237 |
| 23 | MP0004272_abnormal_basement_membrane | 1.87609742 |
| 24 | MP0001958_emphysema | 1.87070228 |
| 25 | MP0003045_fibrosis | 1.85640193 |
| 26 | MP0003091_abnormal_cell_migration | 1.82822460 |
| 27 | MP0001800_abnormal_humoral_immune | 1.80942648 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.76653104 |
| 29 | MP0000747_muscle_weakness | 1.76393426 |
| 30 | MP0004130_abnormal_muscle_cell | 1.75115233 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.73669751 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.69895708 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.69727092 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.68970794 |
| 35 | MP0003436_decreased_susceptibility_to | 1.68538772 |
| 36 | MP0000733_abnormal_muscle_development | 1.64057171 |
| 37 | MP0001879_abnormal_lymphatic_vessel | 1.63366027 |
| 38 | MP0005023_abnormal_wound_healing | 1.61838719 |
| 39 | MP0002269_muscular_atrophy | 1.60593455 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.56891106 |
| 41 | MP0001853_heart_inflammation | 1.56165431 |
| 42 | MP0002006_tumorigenesis | 1.55678014 |
| 43 | MP0006054_spinal_hemorrhage | 1.55596973 |
| 44 | MP0002060_abnormal_skin_morphology | 1.54271910 |
| 45 | MP0003828_pulmonary_edema | 1.53012924 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.51778670 |
| 47 | MP0000767_abnormal_smooth_muscle | 1.51743892 |
| 48 | MP0006138_congestive_heart_failure | 1.50805247 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.50173060 |
| 50 | MP0002896_abnormal_bone_mineralization | 1.48140066 |
| 51 | MP0005670_abnormal_white_adipose | 1.46605419 |
| 52 | MP0009785_altered_susceptibility_to | 1.46225348 |
| 53 | MP0002419_abnormal_innate_immunity | 1.38071036 |
| 54 | MP0004233_abnormal_muscle_weight | 1.37896023 |
| 55 | MP0002723_abnormal_immune_serum | 1.36694099 |
| 56 | MP0009384_cardiac_valve_regurgitation | 1.36566226 |
| 57 | MP0004947_skin_inflammation | 1.35873254 |
| 58 | MP0001299_abnormal_eye_distance/ | 1.35556014 |
| 59 | MP0005451_abnormal_body_composition | 1.34492817 |
| 60 | MP0002933_joint_inflammation | 1.31954520 |
| 61 | MP0002127_abnormal_cardiovascular_syste | 1.30862663 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.28758209 |
| 63 | MP0001819_abnormal_immune_cell | 1.28399657 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.28160195 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.27748881 |
| 66 | MP0000534_abnormal_ureter_morphology | 1.27639607 |
| 67 | MP0001243_abnormal_dermal_layer | 1.26405095 |
| 68 | MP0005671_abnormal_response_to | 1.25707985 |
| 69 | MP0000750_abnormal_muscle_regeneration | 1.24276495 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.22584163 |
| 71 | MP0000003_abnormal_adipose_tissue | 1.22356508 |
| 72 | MP0001542_abnormal_bone_strength | 1.22117860 |
| 73 | MP0005025_abnormal_response_to | 1.21644067 |
| 74 | MP0003448_altered_tumor_morphology | 1.20736510 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.20722769 |
| 76 | MP0003941_abnormal_skin_development | 1.19082107 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.16385168 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.15546792 |
| 79 | MP0002405_respiratory_system_inflammati | 1.13657973 |
| 80 | MP0004484_altered_response_of | 1.13180216 |
| 81 | MP0003724_increased_susceptibility_to | 1.12670445 |
| 82 | MP0009250_abnormal_appendicular_skeleto | 1.12397050 |
| 83 | MP0002168_other_aberrant_phenotype | 1.11911311 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.10466079 |
| 85 | MP0004215_abnormal_myocardial_fiber | 1.10326114 |
| 86 | MP0000343_altered_response_to | 1.09745854 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 1.09232147 |
| 88 | MP0010630_abnormal_cardiac_muscle | 1.08944822 |
| 89 | MP0002332_abnormal_exercise_endurance | 1.07618193 |
| 90 | MP0005390_skeleton_phenotype | 1.07166863 |
| 91 | MP0004087_abnormal_muscle_fiber | 1.06423269 |
| 92 | MP0005595_abnormal_vascular_smooth | 1.05098698 |
| 93 | MP0005508_abnormal_skeleton_morphology | 1.04162780 |
| 94 | MP0005164_abnormal_response_to | 1.03593840 |
| 95 | MP0001661_extended_life_span | 1.03573665 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 1.03308631 |
| 97 | MP0003868_abnormal_feces_composition | 1.01349817 |
| 98 | MP0004084_abnormal_cardiac_muscle | 1.01347471 |
| 99 | MP0002254_reproductive_system_inflammat | 1.01018570 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 1.00157654 |
| 101 | MP0003252_abnormal_bile_duct | 0.98959872 |
| 102 | MP0010386_abnormal_urinary_bladder | 0.98521266 |
| 103 | MP0000716_abnormal_immune_system | 0.96649656 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 0.96563906 |
| 105 | MP0003385_abnormal_body_wall | 0.96239042 |
| 106 | MP0002398_abnormal_bone_marrow | 0.95331127 |
| 107 | MP0000749_muscle_degeneration | 0.93950317 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.93192877 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.90235886 |
| 110 | MP0002128_abnormal_blood_circulation | 0.88922558 |
| 111 | MP0009278_abnormal_bone_marrow | 0.88864236 |
| 112 | MP0003763_abnormal_thymus_physiology | 0.88479360 |
| 113 | MP0003942_abnormal_urinary_system | 0.88342727 |
| 114 | MP0005360_urolithiasis | 0.85433901 |
| 115 | MP0000858_altered_metastatic_potential | 0.84952656 |
| 116 | MP0005330_cardiomyopathy | 0.84696858 |
| 117 | MP0002971_abnormal_brown_adipose | 0.84328794 |
| 118 | MP0005409_darkened_coat_color | 0.84301292 |
| 119 | MP0001873_stomach_inflammation | 0.83887176 |
| 120 | MP0000751_myopathy | 0.83696016 |
| 121 | MP0002108_abnormal_muscle_morphology | 0.83294691 |
| 122 | MP0004134_abnormal_chest_morphology | 0.83254681 |
| 123 | MP0001270_distended_abdomen | 0.82934931 |
| 124 | MP0009764_decreased_sensitivity_to | 0.82211310 |
| 125 | MP0001348_abnormal_lacrimal_gland | 0.82178902 |
| 126 | MP0002396_abnormal_hematopoietic_system | 0.81867767 |
| 127 | MP0008775_abnormal_heart_ventricle | 0.81775343 |
| 128 | MP0000163_abnormal_cartilage_morphology | 0.80806372 |
| 129 | MP0002925_abnormal_cardiovascular_devel | 0.79699879 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.79126760 |
| 131 | MP0003795_abnormal_bone_structure | 0.77845092 |
| 132 | MP0001614_abnormal_blood_vessel | 0.77621146 |
| 133 | MP0000689_abnormal_spleen_morphology | 0.77201384 |
| 134 | MP0000762_abnormal_tongue_morphology | 0.77135517 |
| 135 | MP0009840_abnormal_foam_cell | 0.77076050 |
| 136 | MP0000249_abnormal_blood_vessel | 0.75914405 |
| 137 | MP0005165_increased_susceptibility_to | 0.75242369 |
| 138 | MP0002115_abnormal_skeleton_extremities | 0.75152673 |
| 139 | MP0001666_abnormal_nutrient_absorption | 0.74775733 |
| 140 | MP0002429_abnormal_blood_cell | 0.74575529 |
| 141 | MP0001915_intracranial_hemorrhage | 0.74120507 |
| 142 | MP0005365_abnormal_bile_salt | 0.74057475 |
| 143 | MP0002009_preneoplasia | 0.73415474 |
| 144 | MP0005464_abnormal_platelet_physiology | 0.72872239 |
| 145 | MP0004185_abnormal_adipocyte_glucose | 0.72227068 |
| 146 | MP0002722_abnormal_immune_system | 0.72215346 |
| 147 | MP0005385_cardiovascular_system_phenoty | 0.71483701 |
| 148 | MP0001544_abnormal_cardiovascular_syste | 0.71483701 |
| 149 | MP0002972_abnormal_cardiac_muscle | 0.71473343 |
| 150 | MP0000759_abnormal_skeletal_muscle | 0.70957406 |
| 151 | MP0010329_abnormal_lipoprotein_level | 0.67290182 |
| 152 | MP0000266_abnormal_heart_morphology | 0.65926841 |
| 153 | MP0003283_abnormal_digestive_organ | 0.65892444 |
| 154 | MP0000462_abnormal_digestive_system | 0.63319481 |
| 155 | MP0005167_abnormal_blood-brain_barrier | 0.61831093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.58829828 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.55964932 |
| 3 | Exercise-induced myalgia (HP:0003738) | 4.52964886 |
| 4 | Aortic dissection (HP:0002647) | 4.04503483 |
| 5 | Aortic aneurysm (HP:0004942) | 3.92868483 |
| 6 | Ulnar deviation of the wrist (HP:0003049) | 3.73264198 |
| 7 | Cerebral aneurysm (HP:0004944) | 3.54277793 |
| 8 | Peritonitis (HP:0002586) | 3.32617700 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 3.31790675 |
| 10 | Atrophic scars (HP:0001075) | 3.24341294 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.22071551 |
| 12 | Increased connective tissue (HP:0009025) | 3.18739062 |
| 13 | Asymmetric septal hypertrophy (HP:0001670) | 3.16614966 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 3.15124282 |
| 15 | Increased variability in muscle fiber diameter (HP:0003557) | 3.10822664 |
| 16 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.09232814 |
| 17 | Dilatation of the ascending aorta (HP:0005111) | 3.07154024 |
| 18 | Osteolytic defects of the hand bones (HP:0009699) | 3.03314475 |
| 19 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.03314475 |
| 20 | Hematochezia (HP:0002573) | 3.02152354 |
| 21 | Calf muscle hypertrophy (HP:0008981) | 2.96553911 |
| 22 | Myopathic facies (HP:0002058) | 2.90767729 |
| 23 | Shallow orbits (HP:0000586) | 2.90278814 |
| 24 | Neck muscle weakness (HP:0000467) | 2.87160626 |
| 25 | Slender build (HP:0001533) | 2.79777786 |
| 26 | Overgrowth (HP:0001548) | 2.75954439 |
| 27 | Agammaglobulinemia (HP:0004432) | 2.75536865 |
| 28 | Deep venous thrombosis (HP:0002625) | 2.75394952 |
| 29 | Broad metatarsal (HP:0001783) | 2.75180884 |
| 30 | Neonatal short-limb short stature (HP:0008921) | 2.69731800 |
| 31 | Increased density of long bones (HP:0006392) | 2.67269146 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 2.66114106 |
| 33 | Cellulitis (HP:0100658) | 2.65853409 |
| 34 | Eczematoid dermatitis (HP:0000976) | 2.63615608 |
| 35 | Mitral valve prolapse (HP:0001634) | 2.59751103 |
| 36 | Ankle contracture (HP:0006466) | 2.58253428 |
| 37 | Emphysema (HP:0002097) | 2.57823198 |
| 38 | Calcaneovalgus deformity (HP:0001848) | 2.52969615 |
| 39 | Gastrointestinal stroma tumor (HP:0100723) | 2.51841559 |
| 40 | Soft skin (HP:0000977) | 2.50887973 |
| 41 | Syringomyelia (HP:0003396) | 2.48641960 |
| 42 | Spinal cord lesions (HP:0100561) | 2.48641960 |
| 43 | Absent phalangeal crease (HP:0006109) | 2.44778936 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.42806005 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.40550568 |
| 46 | Cervical subluxation (HP:0003308) | 2.40079747 |
| 47 | Vascular tortuosity (HP:0004948) | 2.39981119 |
| 48 | Rhabdomyolysis (HP:0003201) | 2.38129732 |
| 49 | Follicular hyperkeratosis (HP:0007502) | 2.37737865 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.36235576 |
| 51 | Muscle fiber splitting (HP:0003555) | 2.35470276 |
| 52 | Limited hip movement (HP:0008800) | 2.34858600 |
| 53 | Myocardial infarction (HP:0001658) | 2.34566601 |
| 54 | Fragile skin (HP:0001030) | 2.33995823 |
| 55 | Right ventricular cardiomyopathy (HP:0011663) | 2.30713090 |
| 56 | Deformed tarsal bones (HP:0008119) | 2.30337808 |
| 57 | Myoglobinuria (HP:0002913) | 2.28521071 |
| 58 | Aneurysm (HP:0002617) | 2.27325613 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.25645072 |
| 60 | Abnormality of dentin (HP:0010299) | 2.24515286 |
| 61 | Spinal rigidity (HP:0003306) | 2.23899409 |
| 62 | Sudden death (HP:0001699) | 2.23414338 |
| 63 | Arterial tortuosity (HP:0005116) | 2.20313162 |
| 64 | Difficulty running (HP:0009046) | 2.18095890 |
| 65 | Camptodactyly of toe (HP:0001836) | 2.18086244 |
| 66 | Hip contracture (HP:0003273) | 2.17210084 |
| 67 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.16698244 |
| 68 | Muscle fiber inclusion bodies (HP:0100299) | 2.15868837 |
| 69 | Spondylolisthesis (HP:0003302) | 2.15416100 |
| 70 | Complement deficiency (HP:0004431) | 2.14657564 |
| 71 | Wormian bones (HP:0002645) | 2.14633579 |
| 72 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.14464273 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.11564025 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.11308553 |
| 75 | Recurrent viral infections (HP:0004429) | 2.10494689 |
| 76 | Abnormality of the acetabulum (HP:0003170) | 2.09735652 |
| 77 | Hyporeflexia of lower limbs (HP:0002600) | 2.08587395 |
| 78 | Blue sclerae (HP:0000592) | 2.08362220 |
| 79 | Round ear (HP:0100830) | 2.08214100 |
| 80 | Ulnar bowing (HP:0003031) | 2.07567354 |
| 81 | Scapular winging (HP:0003691) | 2.06364000 |
| 82 | Hypoalphalipoproteinemia (HP:0003233) | 2.06045270 |
| 83 | Colitis (HP:0002583) | 2.05427269 |
| 84 | Malignant hyperthermia (HP:0002047) | 2.04503016 |
| 85 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.03646403 |
| 86 | Subaortic stenosis (HP:0001682) | 2.03646403 |
| 87 | Vasculitis (HP:0002633) | 2.00988004 |
| 88 | Genu recurvatum (HP:0002816) | 2.00740064 |
| 89 | Pulmonary artery stenosis (HP:0004415) | 1.99018233 |
| 90 | Mitral stenosis (HP:0001718) | 1.97548706 |
| 91 | Abnormal finger flexion creases (HP:0006143) | 1.96433860 |
| 92 | Bundle branch block (HP:0011710) | 1.96146265 |
| 93 | Elbow flexion contracture (HP:0002987) | 1.96120908 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 1.96107890 |
| 95 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95870692 |
| 96 | Mitral regurgitation (HP:0001653) | 1.94753142 |
| 97 | Thick nail (HP:0001805) | 1.94124842 |
| 98 | Thin bony cortex (HP:0002753) | 1.93696478 |
| 99 | Abnormal delivery (HP:0001787) | 1.93017678 |
| 100 | Wide anterior fontanel (HP:0000260) | 1.92069848 |
| 101 | Hyperkalemia (HP:0002153) | 1.91975674 |
| 102 | Rimmed vacuoles (HP:0003805) | 1.91583672 |
| 103 | Recurrent bronchitis (HP:0002837) | 1.90492200 |
| 104 | Osteomyelitis (HP:0002754) | 1.89131275 |
| 105 | Ovoid vertebral bodies (HP:0003300) | 1.88748668 |
| 106 | Recurrent fungal infections (HP:0002841) | 1.88065956 |
| 107 | Striae distensae (HP:0001065) | 1.87528452 |
| 108 | Facial diplegia (HP:0001349) | 1.87517848 |
| 109 | Joint contractures involving the joints of the feet (HP:0100492) | 1.87269626 |
| 110 | Flexion contracture of toe (HP:0005830) | 1.87269626 |
| 111 | Myositis (HP:0100614) | 1.86895611 |
| 112 | Aortic regurgitation (HP:0001659) | 1.86796356 |
| 113 | Mediastinal lymphadenopathy (HP:0100721) | 1.86691862 |
| 114 | Rectal prolapse (HP:0002035) | 1.85787171 |
| 115 | Bicuspid aortic valve (HP:0001647) | 1.85652785 |
| 116 | Ventricular tachycardia (HP:0004756) | 1.85116754 |
| 117 | Restrictive lung disease (HP:0002091) | 1.84391174 |
| 118 | Distal lower limb amyotrophy (HP:0008944) | 1.83853477 |
| 119 | Pulmonary infiltrates (HP:0002113) | 1.83040766 |
| 120 | Periodontitis (HP:0000704) | 1.82874070 |
| 121 | Wrist flexion contracture (HP:0001239) | 1.82779796 |
| 122 | Lipoatrophy (HP:0100578) | 1.82630007 |
| 123 | Absent frontal sinuses (HP:0002688) | 1.82464315 |
| 124 | Infantile muscular hypotonia (HP:0008947) | 1.82455928 |
| 125 | Persistence of primary teeth (HP:0006335) | 1.81697785 |
| 126 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.80152988 |
| 127 | Short 4th metacarpal (HP:0010044) | 1.80152988 |
| 128 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79868526 |
| 129 | Dilated cardiomyopathy (HP:0001644) | 1.77889577 |
| 130 | Nemaline bodies (HP:0003798) | 1.77294190 |
| 131 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.76691700 |
| 132 | Abnormality of the calf musculature (HP:0001430) | 1.76539640 |
| 133 | Osteoarthritis (HP:0002758) | 1.76387568 |
| 134 | Inflammation of the large intestine (HP:0002037) | 1.76140972 |
| 135 | Orchitis (HP:0100796) | 1.76124975 |
| 136 | Frequent falls (HP:0002359) | 1.75864072 |
| 137 | Viral hepatitis (HP:0006562) | 1.75544278 |
| 138 | Tibial bowing (HP:0002982) | 1.75465966 |
| 139 | Abnormality of the fingertips (HP:0001211) | 1.75291670 |
| 140 | Hyperextensible skin (HP:0000974) | 1.74325434 |
| 141 | Abnormality of complement system (HP:0005339) | 1.74240670 |
| 142 | Muscle stiffness (HP:0003552) | 1.74169394 |
| 143 | Joint laxity (HP:0001388) | 1.73412350 |
| 144 | Mesomelia (HP:0003027) | 1.72912317 |
| 145 | Biconcave vertebral bodies (HP:0004586) | 1.71521238 |
| 146 | Arterial thrombosis (HP:0004420) | 1.71349620 |
| 147 | Difficulty climbing stairs (HP:0003551) | 1.71081552 |
| 148 | Bladder diverticulum (HP:0000015) | 1.70955146 |
| 149 | Ectopia lentis (HP:0001083) | 1.70179229 |
| 150 | Myotonia (HP:0002486) | 1.70098038 |
| 151 | Hypoplastic ischia (HP:0003175) | 1.69917174 |
| 152 | Distal arthrogryposis (HP:0005684) | 1.69722009 |
| 153 | Abnormality of the ischium (HP:0003174) | 1.69657660 |
| 154 | Abnormality of the calcaneus (HP:0008364) | 1.69648422 |
| 155 | Coxa vara (HP:0002812) | 1.69471166 |
| 156 | Vascular calcification (HP:0004934) | 1.68239988 |
| 157 | Hydroxyprolinuria (HP:0003080) | 1.67033760 |
| 158 | Abnormality of proline metabolism (HP:0010907) | 1.67033760 |
| 159 | Subacute progressive viral hepatitis (HP:0006572) | 1.66838243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.84147795 |
| 2 | MAP3K14 | 2.89102794 |
| 3 | PHKG1 | 2.63581823 |
| 4 | PHKG2 | 2.63581823 |
| 5 | ERN1 | 2.52562497 |
| 6 | MAP4K1 | 2.46804690 |
| 7 | AKT3 | 2.08260254 |
| 8 | TBK1 | 2.05006412 |
| 9 | PIK3CA | 2.04498902 |
| 10 | RIPK1 | 2.04429206 |
| 11 | TGFBR2 | 2.03983504 |
| 12 | DMPK | 2.02282241 |
| 13 | JAK1 | 1.96946277 |
| 14 | TYK2 | 1.96009312 |
| 15 | MAP3K10 | 1.90080109 |
| 16 | STK10 | 1.88541083 |
| 17 | TRIB3 | 1.77744710 |
| 18 | LRRK2 | 1.77335704 |
| 19 | JAK3 | 1.76547341 |
| 20 | LATS1 | 1.66848206 |
| 21 | IKBKB | 1.64711908 |
| 22 | RPS6KA4 | 1.64158250 |
| 23 | FRK | 1.62415080 |
| 24 | NEK9 | 1.62070435 |
| 25 | TIE1 | 1.59535385 |
| 26 | TRPM7 | 1.54662696 |
| 27 | OBSCN | 1.51902854 |
| 28 | LMTK2 | 1.47977322 |
| 29 | IRAK3 | 1.46481699 |
| 30 | CHUK | 1.44255428 |
| 31 | EPHA3 | 1.42974290 |
| 32 | DDR2 | 1.41696247 |
| 33 | STK3 | 1.40953643 |
| 34 | STK38L | 1.40143261 |
| 35 | NUAK1 | 1.39204805 |
| 36 | LATS2 | 1.36373376 |
| 37 | FGFR3 | 1.35496435 |
| 38 | PIK3CG | 1.31132362 |
| 39 | PDGFRA | 1.30173948 |
| 40 | MAP3K13 | 1.29967751 |
| 41 | LIMK1 | 1.29343439 |
| 42 | IKBKE | 1.23025164 |
| 43 | SIK1 | 1.22883014 |
| 44 | MAPKAPK3 | 1.22247916 |
| 45 | KIT | 1.22086108 |
| 46 | MYLK | 1.22023879 |
| 47 | CSK | 1.21825201 |
| 48 | CSF1R | 1.21399961 |
| 49 | RIPK4 | 1.20590896 |
| 50 | CDK12 | 1.19249191 |
| 51 | IRAK4 | 1.18429010 |
| 52 | FGFR4 | 1.17936854 |
| 53 | PTK6 | 1.17223827 |
| 54 | MAP2K3 | 1.16515312 |
| 55 | EPHB1 | 1.14894448 |
| 56 | PAK2 | 1.12814077 |
| 57 | ZAK | 1.07564106 |
| 58 | PKN2 | 1.03534604 |
| 59 | STK38 | 1.02793784 |
| 60 | MARK3 | 0.99595957 |
| 61 | HCK | 0.99508426 |
| 62 | MET | 0.99404349 |
| 63 | EPHB2 | 0.98893232 |
| 64 | ICK | 0.98224922 |
| 65 | BMX | 0.96745205 |
| 66 | BLK | 0.94042459 |
| 67 | TEC | 0.92366388 |
| 68 | MUSK | 0.91936278 |
| 69 | ZAP70 | 0.90835847 |
| 70 | TXK | 0.89463854 |
| 71 | STK24 | 0.89382505 |
| 72 | PDGFRB | 0.89113521 |
| 73 | KDR | 0.88793603 |
| 74 | MAP3K3 | 0.85084295 |
| 75 | CAMK1D | 0.83605395 |
| 76 | PRKG2 | 0.83215409 |
| 77 | MAPK12 | 0.81922120 |
| 78 | ITK | 0.81049107 |
| 79 | BTK | 0.80083752 |
| 80 | MARK1 | 0.80063821 |
| 81 | NTRK2 | 0.80059875 |
| 82 | NTRK1 | 0.79599602 |
| 83 | ERBB3 | 0.78779375 |
| 84 | PIM1 | 0.75821073 |
| 85 | PTK2 | 0.74262334 |
| 86 | CDK6 | 0.74014865 |
| 87 | PRKAA1 | 0.73774088 |
| 88 | MAPK7 | 0.72644384 |
| 89 | WNK4 | 0.70407425 |
| 90 | DYRK1B | 0.69148216 |
| 91 | MOS | 0.67423273 |
| 92 | FGFR1 | 0.66663637 |
| 93 | GRK7 | 0.65688810 |
| 94 | LCK | 0.65152976 |
| 95 | CAMK2G | 0.64552639 |
| 96 | SYK | 0.64140717 |
| 97 | NLK | 0.61865298 |
| 98 | PRKD1 | 0.61646035 |
| 99 | EEF2K | 0.61339096 |
| 100 | ROCK1 | 0.60761088 |
| 101 | ABL1 | 0.60450992 |
| 102 | PRKG1 | 0.60280623 |
| 103 | INSRR | 0.59569503 |
| 104 | TGFBR1 | 0.59390898 |
| 105 | PIM2 | 0.59248794 |
| 106 | SGK2 | 0.58942752 |
| 107 | SGK3 | 0.58813096 |
| 108 | INSR | 0.58712161 |
| 109 | EPHA2 | 0.58520940 |
| 110 | STK39 | 0.57169913 |
| 111 | PTK2B | 0.57167772 |
| 112 | CDC42BPA | 0.56800581 |
| 113 | FER | 0.56191628 |
| 114 | PDK2 | 0.55935585 |
| 115 | MST1R | 0.55803624 |
| 116 | MAP3K6 | 0.55443346 |
| 117 | MST4 | 0.55342736 |
| 118 | LYN | 0.54689064 |
| 119 | MELK | 0.54668652 |
| 120 | MAP2K1 | 0.54639686 |
| 121 | TESK1 | 0.54396410 |
| 122 | PAK3 | 0.53305653 |
| 123 | ILK | 0.53162444 |
| 124 | STK4 | 0.52768913 |
| 125 | MAPKAPK2 | 0.51819621 |
| 126 | RPS6KA2 | 0.50819487 |
| 127 | GSK3A | 0.50599000 |
| 128 | PDPK1 | 0.50549003 |
| 129 | MTOR | 0.49874170 |
| 130 | PRKCH | 0.47796046 |
| 131 | MAPK4 | 0.47706095 |
| 132 | PRKD2 | 0.46868526 |
| 133 | CAMK1G | 0.46175518 |
| 134 | CLK1 | 0.46113084 |
| 135 | SGK494 | 0.45107808 |
| 136 | SGK223 | 0.45107808 |
| 137 | MAP3K7 | 0.44285338 |
| 138 | EGFR | 0.43496570 |
| 139 | TYRO3 | 0.43043900 |
| 140 | CAMK1 | 0.42319841 |
| 141 | WNK1 | 0.42276714 |
| 142 | CAMK2D | 0.42218994 |
| 143 | ROCK2 | 0.41836750 |
| 144 | PRKCQ | 0.40941448 |
| 145 | PAK4 | 0.39732761 |
| 146 | ADRBK1 | 0.39394015 |
| 147 | PNCK | 0.38654153 |
| 148 | PRKAA2 | 0.38380307 |
| 149 | ERBB4 | 0.37947760 |
| 150 | FLT3 | 0.37549878 |
| 151 | RET | 0.36028579 |
| 152 | MAPK11 | 0.35687114 |
| 153 | MARK2 | 0.33618444 |
| 154 | ABL2 | 0.33350826 |
| 155 | MAPK15 | 0.31757524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.99149868 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64299416 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.38867342 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20768033 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11538627 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.07201327 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 1.97604713 |
| 8 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.94310911 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.93426002 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.89760483 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87679490 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87312127 |
| 13 | Focal adhesion_Homo sapiens_hsa04510 | 1.78852597 |
| 14 | Circadian rhythm_Homo sapiens_hsa04710 | 1.78643786 |
| 15 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.78501391 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78497799 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76687857 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.75342375 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.74617024 |
| 20 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.73466709 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.71730975 |
| 22 | Adherens junction_Homo sapiens_hsa04520 | 1.69614590 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.68863792 |
| 24 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.67897686 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63389792 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.62562496 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.60351097 |
| 28 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.57315724 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.51490242 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.47593332 |
| 31 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.46771480 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45124261 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.44962912 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42295411 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.42126955 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41934334 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40811471 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.39823988 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.38956118 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35763440 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.33694167 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.32290008 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31450183 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.30701339 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.29210899 |
| 46 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.29145128 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.28752472 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27239970 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.26073691 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25036798 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23490168 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23235190 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22732327 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.20033695 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17825967 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.16943996 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.16344974 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15237074 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.14829491 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11187360 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09956690 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07999000 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07017395 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 1.04921710 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03668343 |
| 66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03478022 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03277262 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01964681 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.01161531 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00067980 |
| 71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.99905634 |
| 72 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99889180 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.99250202 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98529753 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96832150 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.96828390 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.96407107 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.96364928 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95694500 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.93435307 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92041635 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87472246 |
| 83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87212285 |
| 84 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85937776 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85507313 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85428538 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84850633 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84334888 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.83015992 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82323003 |
| 91 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.81251977 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.80955507 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.80885316 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79998122 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79230326 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.78755907 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77610460 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77558534 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.77220130 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76732962 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76517384 |
| 102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76503236 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76219427 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76063038 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75637738 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74987894 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72326274 |
| 108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71503947 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71433754 |
| 110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70041684 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69836213 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69831916 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67979878 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67405314 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66800410 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66618387 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65761035 |
| 118 | Gap junction_Homo sapiens_hsa04540 | 0.65493414 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64604300 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.63013185 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62481969 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61648670 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61535184 |
| 124 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61122502 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.59946932 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59649648 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59538324 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58424766 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57602756 |
| 130 | Melanoma_Homo sapiens_hsa05218 | 0.56313340 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.56223641 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | 0.55791693 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55616125 |
| 134 | Salivary secretion_Homo sapiens_hsa04970 | 0.55253938 |
| 135 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54768236 |
| 136 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54533589 |
| 137 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54457358 |
| 138 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53195974 |
| 139 | Melanogenesis_Homo sapiens_hsa04916 | 0.51870472 |
| 140 | Axon guidance_Homo sapiens_hsa04360 | 0.51125878 |
| 141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50963169 |
| 142 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50899771 |
| 143 | Insulin secretion_Homo sapiens_hsa04911 | 0.50835459 |
| 144 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49929532 |
| 145 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48778011 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.47881320 |
| 147 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47336900 |
| 148 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47324594 |
| 149 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46541131 |
| 150 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46258399 |
| 151 | Glioma_Homo sapiens_hsa05214 | 0.46160350 |
| 152 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45691942 |
| 153 | Prion diseases_Homo sapiens_hsa05020 | 0.45266853 |
| 154 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45113176 |
| 155 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44928424 |
| 156 | Tight junction_Homo sapiens_hsa04530 | 0.43867183 |
| 157 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43551061 |
| 158 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42966951 |
| 159 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41975166 |
| 160 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41691053 |
| 161 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41293499 |
| 162 | Lysosome_Homo sapiens_hsa04142 | 0.38829442 |
| 163 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38822500 |
| 164 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38496971 |
| 165 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37888775 |
| 166 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37353532 |
| 167 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36761393 |
| 168 | Lysine degradation_Homo sapiens_hsa00310 | 0.36337000 |

